2023.9.4In期刊摘要 Factors Linked to Injection Interval Extension in Eyes with Wet Age-Related Macular Degeneration Switched to Brolucizumab
2023.9.4In期刊摘要 Six Myths of the Anterior Segment: Misunderstandings and Critical Thinking in Ophthalmology
2023.9.4In期刊摘要 Loss to Follow-up in Patients with Neovascular Age-Related Macular Degeneration Treated with AntieVEGF Therapy in the United States in the IRIS Registry
